RWS is pleased to announce the appointment of Jon Hart as Managing Director of RWS Life Sciences, effective 13 May. Jon is highly skilled in revenue and profit growth, with broad experience across the entire value chain including marketing, sales, operations and technology. During his career, Jon has held direct responsibility for sales teams, operations […]
Clarice Streets joins RWS as VP of Quality for Life Sciences Division July 18, 2018 (Hartford, Conn.) – RWS Life Sciences welcomes Clarice Streets, ASQ, CMQ, OE, as Vice President, Global Quality and Process, in charge of the strategic direction and implementation of its Quality system, underlying organizational processes, and change management. A veteran of […]
March 8, 2018 (East Hartford, Conn.) – RWS Life Sciences Managing Director, Sheena Dempsey, will present “Understanding Language Compliance for Global Markets” to the Chicago Chapter of the Regulatory Affairs Professionals Society (RAPS), on March 21, at 5:30 PM (CDT), at AbbVie, Inc., in North Chicago. Dempsey represents the perspective of a language services provider […]
The acquisition of LUZ, Inc. and Corporate Translations, Inc. strengthens RWS’ market leadership and continued growth of life science language services. Hartford, Connecticut—On October 1 2017 RWS, the world’s leading provider of translation, intellectual property, life sciences and language support services, announced a re-launch of its brand, website and divisional structure following a number of […]
Sheena succeeds Mary Gawlicki, who along with Ted Gawlicki founded Corporate Translations in 1990 to fulfill the demand for high quality translation services in the life science industry. RWS Group’s medical translation division was integrated into Corporate Translations this year as part of the acquisition. Sheena will lead the RWS Life Science Division into its […]
The acquisition is in line with the strategy of complementing organic growth with selective acquisition. CTi is based in Connecticut, USA and was founded in 1990 to cater for the growing demand for high quality translation services in the life sciences sector. It is now a recognised leader in successfully managing complex translation projects on […]
The acquisition is in line with RWS’ stated strategy of complementing organic growth with the deployment of the Group’s cash resources for selective acquisitions which have demonstrable growth prospects, offer excellent margins and can enhance shareholder value. PharmaQuest specialises in providing high quality translation and linguistic validation of patient reported outcome measures resulting from clinical […]